Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › CRSP
SR ONE CAPITAL MANAGEMENT, LP position in CRSP
CRISPR THERAPEUTICS AG · Health Care
SR ONE CAPITAL MANAGEMENT, LP reported holding 2,038,763 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q2 2026 13F filing — a position valued at US$111.2M, representing 10.70% of its reported portfolio and ranking #3 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed CRSP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SR ONE CAPITAL MANAGEMENT, LP's CRSP position evolved
SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in CRSP in Q1 2024 at 1,048,951 shares (US$71.5M). The position peaked in Q3 2025 at 2,038,763 shares, worth US$132.1M. Across 10 filings, SR ONE CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 2,038,763 shares valued at US$111.2M. Notable position changes include a 94% increase in Q3 2025 (shares fell 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.05M | $71.50M | New |
| Q2 2024 | 1.05M | $56.65M | Hold |
| Q3 2024 | 1.05M | $49.28M | Hold |
| Q4 2024 | 1.05M | $41.29M | Hold |
| Q1 2025 | 1.05M | $35.70M | Hold |
| Q2 2025 | 1.05M | $51.02M | Hold |
| Q3 2025 | 2.04M | $132.13M | Add |
| Q4 2025 | 2.04M | $106.91M | Hold |
| Q1 2026 | 2.04M | $96.98M | Hold |
| Q2 2026 | 2.04M | $111.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRSP and 13F data
CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 31 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$175.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRSP
- ARK Invest 9.46M sh · $516.00M · Q2 2026
- Orbis Allan Gray Ltd 5.45M sh · $297.20M · Q2 2026
- GSK plc 3.22M sh · $175.65M · Q2 2026
- Amova Asset Management Americas, Inc. 1.72M sh · $93.76M · Q2 2026
- EcoR1 Capital, LLC 1.39M sh · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M sh · $57.73M · Q2 2026
More on SR ONE CAPITAL MANAGEMENT, LP
FAQ
How long has SR ONE CAPITAL MANAGEMENT, LP held CRSP?
SR ONE CAPITAL MANAGEMENT, LP has disclosed CRSP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is SR ONE CAPITAL MANAGEMENT, LP's current position in CRSP?
As of Q2 2026, SR ONE CAPITAL MANAGEMENT, LP holds 2.04M shares of CRSP (CRISPR THERAPEUTICS AG), valued at $111.19M, representing 10.70% of its reported portfolio and ranking #3.
Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling CRSP?
In the latest 13F filing (Q2 2026), SR ONE CAPITAL MANAGEMENT, LP held unchanged its position in CRSP. The position peaked in Q3 2025 at 2.04M shares.
Which other funds hold CRSP?
Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.